Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
J Public Health Res ; 11(2)2021 Nov 22.
Article in English | MEDLINE | ID: covidwho-1534339

ABSTRACT

BACKGROUND: The emergence of the COVID-19 pandemic has changed the delivery of medical care across the world.  The objective of the study is to understand and document the preventive steps implemented on geriatric services in the primary health care centers during COVID-19 pandemic. DESIGN AND METHODS: This is a retrospective study carried on geriatric services utilization (Geriatric clinic- osteoporosis clinic - Memory and dementia clinic) in primary health care centers in Dubai Health Authority in 2020. RESULTS: The study showed that the overall in person visits for all geriatric service in 2020 declined by almost 70%. The total number of telephone consultations in geriatric clinics, osteoporosis clinics and memory clinics were 1479, 1149 and 104 respectively. The COVID-19 pandemic had led to a reduction in most of the geriatric services including outpatient clinics, screening and referral. Telephone consultation provided a foundation for delivery of the service. CONCLUSIONS: This study reflected the potential for telehealth services to bring benefits and convenience to the geriatric population, even after the end of the pandemic.

2.
Rev Med Virol ; 31(3): e2180, 2021 05.
Article in English | MEDLINE | ID: covidwho-815926

ABSTRACT

BACKGROUND: Coagulopathy and thromboembolic events are common in Covid-19 patients and are poor prognostic factors. Controversy exists regarding the potential of anticoagulation (AC) to reduce mortality and incidence of thromboembolic events in Covid-19 patients. The current systematic review and meta-analysis investigated the association between anticoagulants and mortality in adult hospitalized COVID-19 patients using the available published non-randomized studies. METHODS: Google Scholar, PubMed, Scopus, the Cochrane Library and Clinical Trials.gov were searched for relevant studies. A meta-analysis of adjusted and unadjusted estimates was performed. The relative risk was used as a measure of effect. The random-effects model was used to pool estimates using the generic inverse variance method. RESULTS: Sixteen studies were included in the quantitative data synthesis. Results showed a statistically significant association between AC and mortality (RR = 0.56, 95% CI 0.36; 0.92, p = 0.02). Both therapeutic (Relative risk [RR] = 0.4, 95% CI 0.27; 0.57) and prophylactic AC (RR = 0.54, 95% CI 0.41; 0.71) were associated with lower risk of mortality. Pre-admission AC was not associated with mortality (RR = 0.84, 95% CI 0.49; 1.43, p > 0.05) while prophylactic AC was associated with higher risk of mortality compared to therapeutic AC (RR = 1.58, 95% CI 1.34; 1.87, p < 0.001). CONCLUSION: Findings support the association of AC with mortality in Covid-19 patients. The results, synthesized from mostly low-quality studies, show that prophylactic and therapeutic AC might reduce mortality in Covid-19 patients. Findings suggest that therapeutic doses might be associated with better survival compared to prophylactic doses.


Subject(s)
Anticoagulants/therapeutic use , COVID-19 Drug Treatment , Disseminated Intravascular Coagulation/drug therapy , Pulmonary Embolism/drug therapy , SARS-CoV-2/pathogenicity , COVID-19/blood , COVID-19/mortality , COVID-19/pathology , Case-Control Studies , Cohort Studies , Disseminated Intravascular Coagulation/blood , Disseminated Intravascular Coagulation/mortality , Disseminated Intravascular Coagulation/pathology , Drug Administration Schedule , Hospitalization , Humans , Odds Ratio , Pre-Exposure Prophylaxis/methods , Pulmonary Embolism/blood , Pulmonary Embolism/mortality , Pulmonary Embolism/pathology , Risk , SARS-CoV-2/metabolism , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL